Form 4: Acura Pharmaceuticals Director Exercises Stock Options and Acquires Shares

Director Immanuel Thangaraj exercises restricted stock units for Acura Pharmaceuticals common stock and receives additional units.

Summary

• On January 2, 2025, Immanuel Thangaraj, a director of Acura Pharmaceuticals, exercised 50,000 restricted stock units (RSUs) for common stock.
• Thangaraj also acquired an additional 50,000 restricted stock units on the same date.
• Following these transactions, Thangaraj directly owns 497,647 shares of common stock.
• Thangaraj also indirectly owns 1,956,396 shares through Essex Woodlands Health Venture Fund V, L.P., where he is a managing director.
• The RSUs granted on January 2, 2025, vest 25% each quarter, with potential for cash exchange for up to 40% of the units and the remainder exchanged for common stock upon payment of par value.
• Distributions for vested RSUs will be made on the first business day of January 2026 or earlier upon a change of control.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of stock transactions. The director's actions could be interpreted positively, but the document itself is purely informational.

Positives

• The exercise of RSUs and acquisition of additional units by a director could be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The newly granted RSUs vest quarterly, with distributions for vested units starting in January 2026, potentially impacting Thangaraj's holdings and the company's stock structure.

Management Comments

• The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.

Key Dates

Keywords

Acura Pharmaceuticals, Immanuel Thangaraj, restricted stock units, RSUs, common stock, director, beneficial ownership, Essex Woodlands, Form 4, securities